Sign in

CIK 0001649989

  • Non-accelerated filer
  • Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
383982704
Phone
+1 609-619-3990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-05-18 Brady Todd C Director Conversion +66,333 124,303
2016-05-18 Brady Todd C Director Conversion · Series A Preferred Stock −398 0
2016-05-13 Bahrt Kenneth Chief Medical Officer Purchase +2,000 2,000
2016-05-13 Bahrt Kenneth Chief Medical Officer Purchase · Series A Warrants (right to buy) +1,000 1,000
2016-05-13 Bahrt Kenneth Chief Medical Officer Purchase · Series B Warrants (right to buy) +1,000 1,000
2016-05-11 Mohan Pankaj President & CEO Conversion +17,666 39,405

Page 20 of 20 · 386 trades